Skip to main content

Animations

MJFF Publications

3351 - 3360 of 8818 Results
Title
Year
  • Year
  • 2011
  • 2012
  • 2016
  • 2019
  • 2017
  • 2017
  • 2023
  • 2015
  • 2010
  • 2019
  • Summary Details
    RESTRICTED
    Title: Cannabinoid, CB1 agonists in cervical dystonia: Failure in a phase IIa randomized controlled trial
    Journal Name: Basal Ganglia
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.baga.2011.04.002
    Citation Count: 34
  • Summary Details
    OPEN
    Title: Metabotropic glutamate receptor 4 in the basal ganglia of parkinsonian monkeys: Ultrastructural localization and electrophysiological effects of activation in the striatopallidal complex
    Journal Name: Neuropharmacology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neuropharm.2012.05.017
    Citation Count: 41
  • Summary Details
    RESTRICTED
    Title: Near-infrared light (670 nm) reduces MPTP-induced parkinsonism within a broad therapeutic time window
    Journal Name: Experimental Brain Research
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1007/s00221-016-4578-8
    Citation Count: 32
  • Summary Details
    OPEN
    Title: The clinical significance of lower limb tremors
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.06.007
    Citation Count: 13
  • Summary Details
    OPEN
    Title: Alternative microglial activation is associated with cessation of progressive dopamine neuron loss in mice systemically administered lipopolysaccharide
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.nbd.2017.08.009
    Citation Count: 63
  • Summary Details
    RESTRICTED
    Title: Association Between Pathology and Electroencephalographic Activity in Parkinson’s Disease
    Journal Name: Clinical EEG and Neuroscience
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1177/1550059417696179
    Citation Count: 11
  • Summary Details
    OPEN
    Title: In Silico and In Vitro Study towards the Rational Design of 4,4′-Disarylbisthiazoles as a Selective α-Synucleinopathy Biomarker
    Journal Name: International Journal of Molecular Sciences
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/ijms242216445
    Citation Count: 4
  • Summary Details
    RESTRICTED
    Title: NLX-112, a novel 5-HT 1A receptor agonist for the treatment of l -DOPA-induced dyskinesia: Behavioral and neurochemical profile in rat
    Journal Name: Experimental Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.expneurol.2015.05.021
    Citation Count: 73
  • Summary Details
    RESTRICTED
    Title: Evaluation of the Braak staging scheme for Parkinson's disease: Introduction to a panel presentation
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mds.22783
    Citation Count: 21
  • Summary Details
    OPEN
    Title: Unraveling corticobasal syndrome and alien limb syndrome with structural brain imaging
    Journal Name: Cortex
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.cortex.2019.02.015
    Citation Count: 19
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.